Login
Login     |     Register     |     Recover Username/Password

General Investing

Continental Resources (CLR), Approach Resources (AREX) and EOG Resources (EOG) Hold Top Shale and Basin Acreage

January 10, 2013

Some of the best-performing names among oil companies are expected to come from those owning acreage in top-producing U.S. shales and basins like Bakken, Eagle Ford, Permian and Utica, says Leo Mariani, RBC Capital Markets Analyst. These names also display improvement in capital efficiency for 2013.

“One of my favorites is Continental Resources (CLR). I expect to see a number of improvements in the Bakken play during 2013. I expect to see narrower price differentials versus WTI, lower well costs, and just general expansion in inventories in the plays due to successful downspacing and also successful test of the lower benches of the Three Forks reservoir,” Mariani said.

Mariani also likes Approach Resources (AREX), which has exposure to the Permian basin. He expects materially improved capital efficiency and higher production growth out of this company in 2013, and also continued successful horizontal wells drilled in the Permian and in multiple benches of the Wolfcamp.

His final favorite is EOG Resources (EOG), a name with acreage in the Eagle Ford in Texas. “Oil liquids growth, upwards of 30%, we think should occur, and during the year [EOG] may unveil a couple of new oil plays in the U.S., which could certainly add value. We also think they have a decent chance of erasing their free cash flow deficit. They have been outspending cash flow for a number of years, and to really get back much closer to positive by the end of the year, we think should be a catalyst for the company as they continue to ramp cash flow pretty aggressively,” Mariani said.


TSWT - Subscribe now!

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Over 20,000 CEO, Equity Analyst and Money Manager Interviews

TWST Newsletter

Weekly email with New In-Depth Interviews

Most Popular Interviews
Opportunities in Hepatitis C and Genomic Technologies
David Ferreiro

Published April 26, 2014 in Biotechnology and Pharmaceuticals

Buy ($75)
Investing in Health Care Innovation
Finny Kuruvilla

"We’re a faith-based and socially responsible investing firm"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
A Health Sciences Fund with a Long-Term Focus
Mark W. Oelschlager

"The fund is about $40 million in assets"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
High-Yield Canadian Power Companies
John McIlveen

Published May 14, 2013 in High-Yield Equity Securities

Buy ($75)
Most Popular Reports
Investing in Health Care

Published May 16, 2013

Topics Covered: Health Care - Electronic Health Record Adoption - Biotechnology and Pharmaceutical Investing - Biotechnology and Pharmaceuticals - Biotechnology and Pharmaceutical Companies Valuation - Platform Interoperability and Data Analytics - HITECH Act Incentives - Affordable Care Act
Buy ($175)
Internet Services

Published May 10, 2013

Topics Covered: Increased Mobile Content Traffic - Chinese Online Monetization Trends - Internet Infrastructure and Services Consolidation - Social Networking Economics -
Buy ($175)
Investing Strategies

Published May 10, 2013

Topics Covered: Investing in Financial Services - Long-Term Investing - Large Cap Investing - Value Investing - High Quality Companies - Bottom-up Investing - All-Cap Growth Investing - Investing in Emerging Markets
Buy ($175)
Top Company Interviews
TWST
Register for a Free Account to gain greater access to The Wall Street Transcript right now